Cold-chain peptides Refrigerate after reconstitution
In the CY 2023 OPPS/ASC final rule with comment period (87 FR 72250) for CY 2023, we changed the format of the OPPS Addenda A, B, and C by adding a column titled Drug Pass-Through Expiration during Calendar Year to include devices, so that the column reads: Drug and Device Pass-Through Expiration during Calendar Year where we flagged, through the use of an asterisk, each drug and device for which pass-through payment was expiring during the calendar year on a date other than December 31
Vague disclaimers like for research only, but safe for human use: It is a red flag
Separately, its Pharmacy Compounding Advisory Committee reviews seven peptides for section 503A compounding eligibility on July 23-24, 2026
Neurostimulator and Related Procedures (APCs 5461 Through 5465) In the CY 2021 OPPS/ASC final rule with comment period, we finalized a five-level APC structure for the Neurostimulator and Related Procedures series (85 FR 85968 through 85970)
These fat burning injections help optimize metabolism and promote effective weight loss